https://www.selleckchem.com/products/lcl161.html
0 ± 0.9 μg/mL) exhibited more potent anticancer activity. Moreover, most derivatives displayed low hemolytic activity, even at higher concentrations which suggested that these classes of compounds are suitable candidates for further in vivo investigations. The obtained results allow us to consider the newly synthesized isoxazole- and triazole-linked tyrosol derivatives as promising scaffolds for the development of effective anticancer agents.We investigated whether cerebrovascular disease contributes to neurodegeneration and clinical phe
Like
Comment
Share
